Clinical effect of probucol in prevention of contrast induced nephropathy after percutaneous coronary intervention
10.3760/cma.j.issn.1008-6706.2017.10.010
- VernacularTitle:普罗布考预防经皮冠状动脉介入治疗术后造影剂肾病的效果分析
- Author:
Changwu ZHAO
;
Ying ZHANG
;
Jiantao CHEN
- Keywords:
Nephrosis;
Augioplasty;
coronary;
Probucol
- From:
Chinese Journal of Primary Medicine and Pharmacy
2017;24(10):1478-1482
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical effect of probucol in prevention of contrast induced nephropathy(CIN) after percutaneous coronary intervention(PCI).Methods 96 patients with coronary heart disease requiring PCI surgery in our hospital were selected as the research subjects, and they were randomly divided into control group(48 cases) and observation group(48 cases).Both two groups were given traditional treatment, besides this, the observation group was given additional probucol (3 d treatment before and after operation,0.5 g/time,2 times/d).The renal function indicators such as serum creatinine (Scr), cystatin C(CysC), blood urea nitrogen(Bun), estimated glomerular filtration rate(eGFR), and the expression levels of C-reactive protein(CRP),interleukin-6(IL-6) and malondialdehyde(MAD) in the two groups 24 h,48 h, 72 h before and after PCI were observed and compared.And the adverse reactions during operation in the two groups were also recorded and compared.Results There were no significant differences in Scr,CysC,Bun and eGFR between the two groups before opertion(t=0.149,P=0.882;t=1.75,P=0.243;t=0.019,P=0.985).12 h after operation, the Scr,CysC,Bun and eGFR levels in the two groups were gradually increased,48 h post-treatment, the levels reached to the peak and showed a downward trend 72 h after operation;compared with the control group, the rise and decline in the observation group were more greater, and the differences were statistically significant (t=3.242,P=0.002;t=9.532,P<0.001;t=9.073,P<0.001;t=2.896,P<0.001).There were no significant differences in CRP,IL-6 and MAD between the two groups before operation (t=0.321,P=0.749;t=0.014,P=0.989;t=0.188,P=0.850).24 h after operation, the CRP,IL-6 and MAD levels in the two groups were gradually increased,48 h post treatment, the levels reached to the peak and showed a downward trend 72 h after operation;compared with the control group, the rise and decline in the observation group were more greater, and the differences were statistically significant (t=8.495,P=0.002;t=7.532,P<0.00;t=16.216,P<0.001).There were no obvious adverse reactions during operation in the two groups.Conclusion Probucol not only has lipid-regulating and atherosclerotic effects on patients with coronary heart disease, but also has certain preventive and clinical effects to CIN after PCI.Thus, it can be considered as a preferred drug for clinical prevention and treatment of CIN.
